Released on: October 11, 2008, 12:33 am

Press Release Author: Aarkstore.com

Industry: Pharmaceuticals

Press Release Summary: Very little in the pricing environment in Europe is
predictable to pharmaceutical companies and only rarely is much notice given of
change. But before the end of 2009, if the European Court of Justice accepts the
arguments put to it forcefully by the European Commission and by DocMorris,
revolutionary reform among industrys main customer group, the community pharmacist,
in several of the main countries, including 4 of the EU-5, will get the green light.


Press Release Body: The main issue to be resolved, whether national regulations on
pharmacy ownership and establishment of new premises infringe EU law, is of wider
importance than for the pharmacy profession alone. It amounts to a battle over
control of healthcare provision between Brussels and the member states, with the
outcome also of great significance to patients, wholesalers, manufacturers and
payers.

Pharmacy Liberalisation in Europe: Prospects and Implications provides
fully-researched, up-to-date information and interpretation on what deregulation
could mean to all participants in the medicines market. Whether your interest is in
marketing prescription brands, generics or OTCs, in their distribution, or in paying
the bill for them, this report is for you. To be forewarned of what might happen
will allow adequate preparation for it.

The report addresses:

* Background and current status of infringement actions brought by the European
Commission against seven EU member states, plus the key ECJ case involving the
controversial DocMorris pharmacy in the German city of Saarbrucken.
* The arguments for and against reform.
What might happen, who would be the winners and the losers.
* Details of the current ownership structure, and ownership and establishment rules
for pharmacies in countries all across Europe from Iceland to Cyprus.
* Interdependency of pharmacy and wholesaling, and how this could evolve.
What lessons can be found from markets that have already deregulated.
* How vertical integration impacts reimbursement of multisource products and the
response by payers to this.
* The latest on plans to break up Apotekets pharmacy monopoly in Sweden.

For more details please visit:
http://www.aarkstore.com/report/report.asp?ReportId=1050

Web Site: http://www.aarkstore.com

Contact Details: Panvel,
Navi Mumbai,
9272852585
press@aarkstore.com